The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis, a rare form of chronic sinus inflammation driven by hypersensitivity to fungal organisms in the sinuses, in...
Stapokibart, a novel anti–IL-4Rα monoclonal antibody, significantly reduced nasal polyp size and congestion in patients with severe chronic rhinosinusitis with nasal polyps, with improvements evident as...
According to a post hoc analysis, in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, tezepelumab improved nasal and asthma symptoms across multiple...
Do you know when it is recommended a patient undergo endoscopic sinus surgery after a diagnosis of nasal polyps? Test your knowledge with our latest pop quiz to find out!
The American Academy of Otolaryngology and the American Academy of Family Practice recommend obtaining a thorough history, conducting a nasal examination, and administering a sinus computed tomography scan...
Eosinophils are commonly used to predict asthma severity. In your opinion, do you think eosinophil levels can be used to categorize the severity of nasal polyps as well?
Do you know if nasal polyps in patients younger than age 20 years should raise suspicion for other clinical conditions? Test your knowledge with our latest pop quiz to find out!
In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.
In this Q&A, Edward Kuan, MD, answers our questions about nasal polyps, including their clinical characteristics, prevalence, surgery recommendations, and recurrence rates.